The Universal Selection Source:
Plastics & Elastomers
Product News

Lubrizol at Muovi Plastics: Featured Medical-grade TPUs, Rubber-replacing Soft Polymers

Published on 2014-12-04. Author : SpecialChem

CLEVELAND -- The Lubrizol Corporation highlighted its LifeSciences’ extensive portfolio of advanced materials for the medical device industry at the Muovi Plastics exhibition November 12-14 at the Lahti Fair Centre in Lahti, Finland. One of the leading Danish raw material distributors Bjorn Thorsen A/S, based in Copenhagen, represents Lubrizol in the Nordic region and showcased the material supplier’s broad product range at its booth (E6D).

Lubrizol’s recent acquisition of Vesta, among the leading contract manufacturers for the global medical device industry, expands Lubrizol's life science manufacturing capabilities, applications and long term implantable material portfolio with access to silicone and a variety of other thermoplastics utilized in medical devices.

“With our broad product portfolio we are firmly positioned as a strategic supplier to the healthcare industry in the Nordic region,” said Timothy Madden, Lubrizol managing director for the Europe, Middle East and Asia (EMEA) region. “We have teamed with key partners like Bjorn Thorsen and we are committed to the development of innovative material solutions to help support and drive the medical device market.”

Madden added that Lubrizol LifeSciences is developing new and innovative medical-grade thermoplastic polyurethane (TPU) solutions for medical device manufacturers that meet the stringent requirements of the healthcare industry and also deliver safe and effective patient care. The latest technologies from Lubrizol include breathable polymers for wound care, flame retardant TPUs for medical devices, soft polymers as an alternative for silicones and rubbers, and pharmaceutical-grade Pathway™ excipients.

Among the featured products at Muovi Plastics were Tecothane™ TPUs which are the first medical-grade TPUs that also offer flame-retardant properties. This innovation can be used in applications such as touchscreen monitors, pressure cuffs, EKG cables, sensor cables and more. Flame-retardant technology is a critical feature in home care and medical applications where the growing use of electronics can mean an increased probability of equipment short-circuiting. It withstands repeated high heat and harsh chemical sterilization cycles without breaking down. Flame retardant Tecothane TPU also delivers a variety of special-effect properties such as a matte finish, soft touch and low dust tackiness.

Another new featured innovation is Pathway™ TPU excipients — a customizable, reliable choice for drug delivery. Pathway TPU excipients are manufactured in compliance with Good Manufacturing Practices (GMP) for use in non-biodegradable drug implants such as vaginal rings and subcutaneous drug delivery systems. They are also used in devices where manufacturers have a desire for a higher quality standard due to the increasingly stringent regulatory environment. This new development for controlled release drug delivery is strengthened by Lubrizol’s proven expertise in TPU formulation, GMP manufacturing and regulatory agility from decades of work in the pharmaceutical excipient market.

Lubrizol recently launched new medical-grade aromatic TPU products that will serve to augment its Pellethane® line of products. The new additions to the Pellethane line are a mix of polyester and polyether aromatic TPU products that offer a wide range of properties that make them ideal for use in the medical industry. The new products offer high moisture vapor transmission rate (MVTR) for advanced wound care applications; stiffness and non-kinking properties for multifunctional medical device applications such as tubing, backings, film or catheters; and other properties useful in applications such as medical garments and drapes.

The product portfolio also includes an expanded line of Tecothane™ Soft polymers designed specifically for medical applications. These new soft polymers offer an alternative to materials such as rubbers and silicones, while providing the benefits of a thermoplastic polymer. Mechanical properties include strong tear resistance, excellent resilience and recoverability. Finally, they are suitable for a wide range of sterilization methods commonly found in hospitals, including hydrogen peroxide.

Pellethane® is a registered trademark of The Lubrizol Corporation.
Tecothane™ is a trademark of The Lubrizol Corporation.

About Bjorn Thorsen A/S

Bjorn Thorsen A/S, based in Copenhagen, Denmark, is among the leading distributors of raw materials for specific segments of the chemical industry. From its offices in Denmark and Sweden, the company represents the leading manufacturers of specialized raw materials and offers a broad product line in stock at strategically located warehouses throughout the Nordic region. The company has a strong industry position and the capability to provide its customer base with technical and processing know-how and efficient logistical services.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers’ products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and pharmaceuticals, and specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 7,500 employees worldwide. Revenues for 2013 were $6.4 billion.

Source: Lubrizol Corporation

ForTii Ace
The Chemicals Sales & Marketing Toolbox
Back to Top